Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relationship Between Brain and Heart Glucose Metabolism in Alcohol Use Disorder
NCT05015881Phase 3Enrolling by invitation
- Sponsor
- University of Pennsylvania
- Start
- Nov 2021
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 3, open-label trial (2 arms), sponsored by University of Pennsylvania. Primary endpoint: FDG uptake in the brain and heart at 4 hours. Started Nov 2021; status: enrolling by invitation.
Beyond the preview
Go deeper on NCT05015881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05015881.